Sales of contact lenses by Johnson & Johnson declined by 0.3 percent in the second quarter to $842 million. Operational growth, which excludes currency fluctuations, reached 2.4 percent, driven by daily disposable and astigmatism lenses from the Oasys range. For the whole of J&J's vision care division, sales were down by 1.0 percent to $1.161 billion, but operational growth reached 1.5 percent.